ETF constituents for IDNA

Below, a list of constituents for IDNA (iShares Genomics Immunology and Healthcare ETF) is shown. In total, IDNA consists of 53 securities.

Note: The data shown here is as of date Jun 30, 2022 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Join the Alphalerts Newsletter

Lot's of cool shit - financial research, unusual stock/option/crypto picks,
tutorials on how to build a fintech SaaS, free data and feature updates.

Ticker Name Sector Asset Class Market Value Weight (%)
BEAM BEAM THERAPEUTICS INC Health Care Equity 11208487.62 5.63
NTLA INTELLIA THERAPEUTICS INC Health Care Equity 9522051.36 4.78
NVAX NOVAVAX INC Health Care Equity 8675975.13 4.36
FATE FATE THERAPEUTICS INC Health Care Equity 8649729.07 4.34
MRNA MODERNA INC Health Care Equity 8523490.96 4.28
6160 BEIGENE LTD Health Care Equity 8363881.07 4.2
GMAB GENMAB Health Care Equity 8360890.73 4.2
EXEL EXELIXIS INC Health Care Equity 7827573.64 3.93
4528 ONO PHARMACEUTICAL LTD Health Care Equity 7568296.3 3.8
BNTX BIONTECH SE ADR Health Care Equity 7460816.4 3.75
4502 TAKEDA PHARMACEUTICAL LTD Health Care Equity 7068817.81 3.55
TWST TWIST BIOSCIENCE CORP Health Care Equity 6983440.92 3.51
GILD GILEAD SCIENCES INC Health Care Equity 6708730.0 3.37
EVT EVOTEC Health Care Equity 6703439.72 3.37
ROG ROCHE HOLDING PAR AG Health Care Equity 6619955.9 3.32
VIR VIR BIOTECHNOLOGY INC Health Care Equity 6301384.47 3.16
SAN SANOFI SA Health Care Equity 6155263.84 3.09
REGN REGENERON PHARMACEUTICALS INC Health Care Equity 6148463.3 3.09
BPMC BLUEPRINT MEDICINES CORP Health Care Equity 6129089.22 3.08
IOVA IOVANCE BIOTHERAPEUTICS INC Health Care Equity 5078502.95 2.55
LGND LIGAND PHARMACEUTICALS INC Health Care Equity 4616500.89 2.32
RCUS ARCUS BIOSCIENCES INC Health Care Equity 3668781.84 1.84
EDIT EDITAS MEDICINE INC Health Care Equity 3401494.36 1.71
FGEN FIBROGEN INC Health Care Equity 3364131.02 1.69
6547 MEDIGEN VACCINE BIOLOGICS CORP Health Care Equity 3274974.12 1.64
ALLO ALLOGENE THERAPEUTICS INC Health Care Equity 3209668.44 1.61
VLA VALNEVA Health Care Equity 2504174.09 1.26
CVAC CUREVAC NV Health Care Equity 2186730.0 1.1
AGEN AGENUS INC Health Care Equity 1961571.42 0.98
CHRS COHERUS BIOSCIENCES INC Health Care Equity 1919801.73 0.96
GOSS GOSSAMER BIO INC Health Care Equity 1700817.19 0.85
SGMO SANGAMO THERAPEUTICS INC Health Care Equity 1451349.9 0.73
VXRT VAXART INC Health Care Equity 1445397.28 0.73
INO INOVIO PHARMACEUTICALS INC Health Care Equity 1392854.76 0.7
NVTA INVITAE CORP Health Care Equity 1335339.0 0.67
RAPT RAPT THERAPEUTICS INC Health Care Equity 1314082.8 0.66
4142 ADIMMUNE CORP Health Care Equity 1301018.67 0.65
NGM NGM BIOPHARMACEUTICALS INC Health Care Equity 931223.28 0.47
XTSLA BLK CSH FND TREASURY SL AGENCY Cash and/or Derivatives Money Market 210000.0 0.11
USD USD CASH Cash and/or Derivatives Cash 148642.41 0.07
EUR EUR CASH Cash and/or Derivatives Cash 43308.49 0.02
JPY JPY CASH Cash and/or Derivatives Cash 40692.77 0.02
HKD HKD CASH Cash and/or Derivatives Cash 23278.69 0.01
DKK DKK CASH Cash and/or Derivatives Cash 20869.59 0.01
HBCFT CASH COLLATERAL USD HBCFT Cash and/or Derivatives Cash Collateral and Margins 20000.0 0.01
CHF CHF CASH Cash and/or Derivatives Cash 19230.63 0.01
TWD TWD CASH Cash and/or Derivatives Cash 14879.33 0.01
GBP GBP CASH Cash and/or Derivatives Cash 28.68 0.0
IXCU2 E-MINI HEALTH CARE SECTOR SEP 22 Cash and/or Derivatives Futures 0.0 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY VEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Barclays, Bloomberg Finance L.P., BlackRock Index Services, LLC, Cohen & Steers Capital Management, Inc., European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Services, LLC, India Index Services & Products Limited, JPMorgan Chase & Co., Japan Exchange Group, MSCI Inc., Markit Indices Limited, Morningstar, Inc., The NASDAQ OMX Group, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), New York Stock Exchange, Inc., Russell or S&P Dow Jones Indices LLC. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE nor NAREIT makes any warranty regarding the FTSE NAREIT Equity REITS Index, FTSE NAREIT All Residential Capped Index or FTSE NAREIT All Mortgage Capped Index; all rights vest in NAREIT. Neither FTSE nor NAREIT makes any warranty regarding the FTSE EPRA/NAREIT Developed Real Estate ex-U.S. Index, FTSE EPRA/NAREIT Developed Europe Index or FTSE EPRA/NAREIT Global REIT Index; all rights vest in FTSE, NAREIT and EPRA.“FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2021 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc., or its subsidiaries. All other marks are the property of their respective owners. ICRMH0421U/S-1620308 nan nan nan nan nan